EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,407,000 | -22.6% | 33,706 | -13.6% | 0.00% | 0.0% |
| Q4 2020 | $1,817,000 | +3.8% | 39,006 | -5.3% | 0.00% | -33.3% |
| Q3 2020 | $1,750,000 | -45.0% | 41,206 | -37.8% | 0.00% | -40.0% |
| Q2 2020 | $3,181,000 | -18.1% | 66,289 | -21.5% | 0.01% | -37.5% |
| Q1 2020 | $3,886,000 | +17.9% | 84,470 | +53.9% | 0.01% | +33.3% |
| Q4 2019 | $3,297,000 | -49.4% | 54,870 | -52.3% | 0.01% | -14.3% |
| Q3 2019 | $6,514,000 | +74.5% | 115,140 | +71.7% | 0.01% | -12.5% |
| Q2 2019 | $3,733,000 | -26.4% | 67,052 | -33.2% | 0.01% | -27.3% |
| Q1 2019 | $5,069,000 | +88.1% | 100,400 | +50.1% | 0.01% | +57.1% |
| Q4 2018 | $2,695,000 | -15.3% | 66,900 | +45.8% | 0.01% | 0.0% |
| Q3 2018 | $3,182,000 | -18.5% | 45,900 | -11.0% | 0.01% | -22.2% |
| Q2 2018 | $3,904,000 | +24.1% | 51,600 | -13.6% | 0.01% | +12.5% |
| Q1 2018 | $3,146,000 | +94.3% | 59,700 | +97.0% | 0.01% | +100.0% |
| Q4 2017 | $1,619,000 | -13.0% | 30,300 | -2.9% | 0.00% | -20.0% |
| Q3 2017 | $1,861,000 | – | 31,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |